ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,970.84
      -1.11%
      US Tech 100
      20,922.80
      -1.23%
      Dow Jones
      42,992.21
      -0.77%
      Brent Oil
      73.435
      0.75%
      Bitcoin
      94,484.15
      -1.26%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. BioNTech SE (22UA) Quote

      BioNTech SE

      BioNTech SE (22UA)

      TG
      109.40
      0.20
      (0.18%)
      Closed December 27 4:00PM
      Realtime Data

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      109.40
      Bid
      109.10
      Ask
      109.60
      Volume
      33,142
      108.10 Day's Range 110.40
      69.55 52 Week Range 118.50
      Market Cap
      26.007B
      Previous Close
      109.20
      Open
      108.50
      Last Trade
      23
      @
      109.4
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      40,784
      Shares Outstanding
      237,725,735
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      3.82B
      Net Profit
      930.3M

      About BioNTech SE

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.biontech.de
      Headquarters
      Mainz, Deu
      Founded
      -
      BioNTech SE is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 22UA. The last closing price for BioNTech was 109.20 €. Over the last year, BioNTech shares have traded in a share price range of 69.55 € to 118.50 €.

      BioNTech currently has 237,725,735 shares outstanding. The market capitalization of BioNTech is 25.96 € billion.

      Ask ADVFN Intelligence (AI)

      22UA Latest News

      More News

      BioNTech kündigt Übernahme von Biotheus zur beschleunigten Umsetzung der Onkologie-Strategie an

      BioNTech kündigt Übernahme von Biotheus zur beschleunigten Umsetzung der Onkologie-Strategie an Übernahme soll globale Umsetzung von BioNTechs Onkologie-Strategie unterstützen und die weltweiten...

      November 13 2024
      UK Regulatory

      BioNTech to Acquire Biotheus to Boost Oncology Strategy

      BioNTech to Acquire Biotheus to Boost Oncology Strategy Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an...

      November 13 2024
      UK Regulatory

      BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie Informationen zur Geschäftsentwicklung

      BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie Informationen zur Geschäftsentwicklung Veröffentlichung klinischer Daten für mehrere Produktkandidaten aus verschiedenen...

      November 04 2024
      UK Regulatory

      BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

      BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002...

      November 04 2024
      UK Regulatory

      BioNTech veranstaltet am 14. November 2024 „Innovation Series Day“ zu Forschung & Entwicklung

      BioNTech veranstaltet am 14. November 2024 „Innovation Series Day“ zu Forschung & Entwicklung MAINZ, Deutschland, 31. Oktober 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“...

      October 31 2024
      UK Regulatory

      BioNTech to Host Innovation Series R&D Day on November 14, 2024

      BioNTech to Host Innovation Series R&D Day on November 14, 2024 MAINZ, Germany, October 31, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an...

      October 31 2024
      UK Regulatory

      BioNTech veröffentlicht am 4. November 2024 Ergebnisse für das dritte Quartal 2024 und informiert über operativen Fortschritt

      BioNTech veröffentlicht am 4. November 2024 Ergebnisse für das dritte Quartal 2024 und informiert über operativen Fortschritt MAINZ, Deutschland, 21. Oktober 2024 (GLOBE NEWSWIRE) -- BioNTech SE...

      October 21 2024
      UK Regulatory

      BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

      BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the...

      October 21 2024
      UK Regulatory

      BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day

      BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy...

      October 01 2024
      UK Regulatory

      BioNTech stellt auf dem ersten „AI Day” ihre Fähigkeiten im Bereich Künstliche Intelligenz und deren Anwendung in der Forschung und Entwicklung vor

      BioNTech stellt auf dem ersten „AI Day” ihre Fähigkeiten im Bereich Künstliche Intelligenz und deren Anwendung in der Forschung und Entwicklung vor BioNTech stellt vor, wie unternehmenseigene...

      October 01 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      13.33.11027332705106.1110.4104.533568108.71592737DE
      4-4.5-3.95083406497113.9118.5104.540136111.82928948DE
      121.21.10905730129108.2118.589.5540784106.54053588DE
      2632.1541.618122977377.25118.569.554337996.65093188DE
      5214.415.157894736895118.569.554266291.96007189DE
      156-116.8-51.6357206012226.2229.669.5575782131.50239538DE
      26031.440.25641025647839565.5127082163.66287049DE

      22UA - Frequently Asked Questions (FAQ)

      What is the current BioNTech share price?
      The current share price of BioNTech is 109.40 €
      How many BioNTech shares are in issue?
      BioNTech has 237,725,735 shares in issue
      What is the market cap of BioNTech?
      The market capitalisation of BioNTech is EUR 25.96B
      What is the 1 year trading range for BioNTech share price?
      BioNTech has traded in the range of 69.55 € to 118.50 € during the past year
      What is the reporting currency for BioNTech?
      BioNTech reports financial results in EUR
      What is the latest annual turnover for BioNTech?
      The latest annual turnover of BioNTech is EUR 3.82B
      What is the latest annual profit for BioNTech?
      The latest annual profit of BioNTech is EUR 930.3M
      What is the registered address of BioNTech?
      The registered address for BioNTech is AN DER GOLDGRUBE 12, MAINZ, 55131
      What is the BioNTech website address?
      The website address for BioNTech is www.biontech.de
      Which industry sector does BioNTech operate in?
      BioNTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      Z4UreAlpha Tech Corp
      2.60 €
      (114.70%)
      		8.05k
      510Graphex Group Limited
      0.392 €
      (106.32%)
      		16.46k
      34Q0Quantum eMotion Inc
      0.73 €
      (103.91%)
      		2.99M
      M000Vertical Aerospace Ltd
      14.50 €
      (101.39%)
      		8.16k
      2WOWide Open Agriculture Ltd
      0.01 €
      (100.00%)
      		18k
      ANLAnalog Devices Inc
      9.6728 €
      (-95.32%)
      		1.25k
      E3O1Nexoptic Technology Corp
      0.007 €
      (-62.16%)
      		12.62k
      WWTWater Ways Technologies Inc
      0.003 €
      (-50.00%)
      		181.5k
      1RR1Rokmaster Resources Corp
      0.006 €
      (-50.00%)
      		19k
      7CCCheckCap Ltd
      1.14 €
      (-47.22%)
      		265
      PF8European Lithium Limited
      0.024 €
      (18.81%)
      		14.01M
      D7GNel ASA
      0.2429 €
      (-3.07%)
      		5.39M
      RQ0DWave Quantum Inc
      9.474 €
      (21.03%)
      		3.1M
      34Q0Quantum eMotion Inc
      0.73 €
      (103.91%)
      		2.99M
      M11First Graphene Limited
      0.019 €
      (4.40%)
      		2.5M

      Discussion

      View Full Feed
      Tiger Money Tiger Money 2 minutes ago
      I thought I'm was as bad at technology.  Just kidding 
      https://x.com/saylor/status/1872362068579619308?s=46&t=BhTJBtmkPHgCEZtP09Ehxw
      KULR
      diggitydoodle diggitydoodle 3 minutes ago
      Another week ends with this ticker exactly where it has been for the past 3 years.
      Worthless to trips 1, and back down again over and over.
      Maybe next week starts the New Year with some good news.
      RNVA!!$$???????????????????
      RNVA
      devil dog 96 devil dog 96 3 minutes ago
      Got me some more .0011's again today. 🔥 Glad management is giving us this time to build our positions before they announce their next story and start their marketing.

      I'm not much of an ASK slapper on micro float bottom plays like this so it takes me a bit longer to load then
      CRSM
      I-Glow I-Glow 3 minutes ago
      Wrong board don't be pumping another OTC stock on the Spooz board - that is pretty shady.

      I guess I will take a look at it.

      IG
      SPZI
      BullNBear52 BullNBear52 3 minutes ago
      We have seen this before with BBBY. They filed BK told their shareholders it was getting delisted and still it was traded.

      And now rats are leaving a sinking ship and the stock goes up. Pity the fools who bought at the high today.
      DrHigh DrHigh 4 minutes ago
      We move at the speed of molasses. If DCVax is going to save any lives, the platform needs to get into the hands of competent leadership
      NWBO
      Catmandoo Catmandoo 4 minutes ago
      # 18 on Breakout Boards ..bashers actually giving this more exposure, bunch of dummies
      HMBL
      FeMike FeMike 4 minutes ago
      The only rational reason I can construct for taking so long is that he expects his decision to be precedent setting.


      It's really funny that NWBO is so comically slow in everything they do, they have even managed to slow down the United States judicial system, which is already
      NWBO
      Slojab Slojab 4 minutes ago
      The Expert Market is going nowhere. I don't know where you heard that nonsense but I'd love to know your source of information. Can you provide a link?
      USEI
      capgain capgain 5 minutes ago
      Yep.
      JamesF1 JamesF1 5 minutes ago
      6 digits after the decimal point! That seems ridiculous.
      ELTP
      Bull_Dolphin Bull_Dolphin 5 minutes ago
      I'm with you on this one kk. We've got plenty of talent right here and too often these H1B's have been used to jettison higher paid talent.
      CommodityCoverage CommodityCoverage 6 minutes ago
      Clinical-stage biotech company, Thiogenesis Therapeutics (TTI.v), is advancing TTI-0102, a prodrug designed to revolutionize the treatment of rare mitochondrial diseases like MELAS and Leigh Syndrome: https://x.com/StckMasterFlash/status/1871347807430291939

      With patent protection unti
      TTI
      plexrec plexrec 7 minutes ago
      "-What day and time will Anavex be presenting ?"--surprised no one here able to ANSWER THIS !!
      AVXL
      glenn1919 glenn1919 7 minutes ago
      muln.............................slapthebottom..............................https://www.stockscores.com/charts/charts/?ticker=MULN
      MULN
      3331 3331 7 minutes ago
      You're kidding right? NO

      Just by asking that question says everything!! IT SAYS YOU CAN'T ANSWER!

      You DO know that more outstanding shares minimizes your personal % investment in the company? WRONG

      CLEARLY, YOU DON'T KNOW WHAT YOU'RE TALKING ABOUT AND
      BIEL
      fink fink 8 minutes ago
      Yes, we got no more .09s today. Lord knows I put some cash there too.

      Anything below.12 helps my overall. I'll empty my war chest in last 15 second Tuesday.
      AZRH
      TenKay TenKay 8 minutes ago
      OMG…conspiracy theory much? LOL.

      I post for myself. I am not posting on anyone else’s behalf. I don’t get paid for posting.

      Satisfied?

      smh.
      HMBL
      georgie18 georgie18 8 minutes ago
      VINC...40s clearing here...🥳

      georgie18

      Member Level
      Re: georgie18 post# 29

      Friday, December 27, 2024 4:19:41 PM

      Post#
      30
      of 30
      VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2
      VINC
      gitreal gitreal 8 minutes ago
      Aha, so you're a cheater. Who admires an OTC CEO.....who is also a cheater.

      Checks out.
      NBRI
      georgie18 georgie18 8 minutes ago
      VINC...40s clearing here...🥳

      georgie18

      Member Level
      Re: georgie18 post# 29

      Friday, December 27, 2024 4:19:41 PM

      Post#
      30
      of 30
      VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2
      VINC
      roxandbonz roxandbonz 8 minutes ago
      This is heading up with insiders buying. TMC up today 25 percent. Looking for $50.00 on this one. Just need the permit approved.
      TMC
      georgie18 georgie18 9 minutes ago
      VINC...40s clearing here...🥳

      georgie18

      Member Level
      Re: georgie18 post# 29

      Friday, December 27, 2024 4:19:41 PM

      Post#
      30
      of 30
      VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2
      VINC

      Your Recent History

      TG
      22UA
      BioNTech
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads